FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data
10 Nov 2023 //
BUSINESSWIRE
FORE Biotherapeutics to Present Plixorafenib Nonclinical Data
12 Oct 2023 //
BUSINESSWIRE
10 Nov 2023 //
BUSINESSWIRE
12 Oct 2023 //
BUSINESSWIRE